Literature DB >> 15931453

Trends and outcome of nosocomial and community-acquired bloodstream infections due to Staphylococcus aureus in Finland, 1995-2001.

O Lyytikäinen1, E Ruotsalainen, A Järvinen, V Valtonen, P Ruutu.   

Abstract

In Finland, Staphylococcus aureus bloodstream infections are caused predominantly (>99%) by methicillin-sensitive strains. In this study, laboratory-based surveillance data on Staphylococcus aureus bloodstream infections occurring in Finland from 1995 to 2001 were analyzed. Preceding hospitalizations for all persons with Staphylococcus aureus bloodstream infections were obtained from the national hospital discharge registry, and data on outcome was obtained from the national population registry. An infection was defined as nosocomial when a positive blood culture was obtained more than 2 days after hospital admission or within 2 days of admission if there was a preceding hospital discharge within 7 days. A total of 5,045 cases were identified. The annual incidence of Staphylococcus aureus bloodstream infection rose by 55%, from 11 per 100,000 population in 1995 to 17 in 2001. The increase was detected in all adult age groups, though it was most distinct in patients >74 years of age. Nosocomial infections accounted for 51% of cases, a proportion that remained unchanged. The 28-day death-to-case ratio ranged from 1% in the age group 1-14 years to 33% in patients >74 years of age. The 28-day death-to-case ratios for nosocomial and community-acquired infections were 22% and 13%, respectively, and did not change over time. The increase in incidence among elderly persons resulted in an increase in the annual rate of mortality associated with Staphylococcus aureus bloodstream infections, from 2.6 to 4.2 deaths per 100,000 population per year. Staphylococcus aureus bloodstream infections are increasing in Finland, a country with a very low prevalence of methicillin resistance. While the increase may be due in part to increased reporting, it also reflects a growing population at risk, affected by such factors as high age and/or severe comorbidity.

Entities:  

Mesh:

Year:  2005        PMID: 15931453     DOI: 10.1007/s10096-005-1345-3

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  21 in total

1.  Risk factors for hospital-acquired Staphylococcus aureus bacteremia.

Authors:  A G Jensen; C H Wachmann; K B Poulsen; F Espersen; J Scheibel; P Skinhøj; N Frimodt-Møller
Journal:  Arch Intern Med       Date:  1999-07-12

2.  Staphylococcus aureus bacteremia among elderly vs younger adult patients: comparison of clinical features and mortality.

Authors:  R S McClelland; V G Fowler; L L Sanders; G Gottlieb; L K Kong; D J Sexton; K Schmader; K D Lanclos; R Corey
Journal:  Arch Intern Med       Date:  1999-06-14

3.  Long-term outcome and quality of care of patients with Staphylococcus aureus bacteremia.

Authors:  G Fätkenheuer; M Preuss; B Salzberger; N Schmeisser; O A Cornely; H Wisplinghoff; H Seifert
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2004-02-25       Impact factor: 3.267

4.  MRSA bacteraemia: North/South Study of MRSA in Ireland 1999.

Authors:  P Mc Donald; E Mitchell; H Johnson; A Rossney; H Humphreys; G Glynn; M Burd; D Doyle; R Mc Donnell
Journal:  J Hosp Infect       Date:  2002-12       Impact factor: 3.926

5.  All Wales surveillance of methicillin-resistant Staphylococcus aureus (MRSA): the first year's results.

Authors:  M Morgan; R Salmon; N Keppie; D Evans-Williams; I Hosein; D N Looker
Journal:  J Hosp Infect       Date:  1999-03       Impact factor: 3.926

6.  Treatment and outcome of Staphylococcus aureus bacteremia: a prospective study of 278 cases.

Authors:  Allan G Jensen; Carsten H Wachmann; Frank Espersen; Jens Scheibel; Peter Skinhøj; Niels Frimodt-Møller
Journal:  Arch Intern Med       Date:  2002-01-14

7.  Population-based study of the epidemiology of and the risk factors for invasive Staphylococcus aureus infections.

Authors:  Kevin B Laupland; Deirdre L Church; Melissa Mucenski; Lloyd R Sutherland; H Dele Davies
Journal:  J Infect Dis       Date:  2003-04-15       Impact factor: 5.226

8.  Increasing rates of hospitalization due to septicemia in the US elderly population, 1986-1997.

Authors:  M McBean; S Rajamani
Journal:  J Infect Dis       Date:  2001-01-17       Impact factor: 5.226

9.  Secular trends in nosocomial primary bloodstream infections in the United States, 1980-1989. National Nosocomial Infections Surveillance System.

Authors:  S N Banerjee; T G Emori; D H Culver; R P Gaynes; W R Jarvis; T Horan; J R Edwards; J Tolson; T Henderson; W J Martone
Journal:  Am J Med       Date:  1991-09-16       Impact factor: 4.965

10.  Nosocomial and community-acquired Staphylococcus aureus bacteremias from 1980 to 1993: impact of intravascular devices and methicillin resistance.

Authors:  J P Steinberg; C C Clark; B O Hackman
Journal:  Clin Infect Dis       Date:  1996-08       Impact factor: 9.079

View more
  27 in total

1.  Incidence, treatment, and outcome of severe sepsis in ICU-treated adults in Finland: the Finnsepsis study.

Authors:  Sari Karlsson; Marjut Varpula; Esko Ruokonen; Ville Pettilä; Ilkka Parviainen; Tero I Ala-Kokko; Elina Kolho; Esa M Rintala
Journal:  Intensive Care Med       Date:  2007-01-16       Impact factor: 17.440

2.  Phase II, randomized, double-blind, multicenter study comparing the safety and pharmacokinetics of tefibazumab to placebo for treatment of Staphylococcus aureus bacteremia.

Authors:  J John Weems; James P Steinberg; Scott Filler; John W Baddley; G Ralph Corey; Priya Sampathkumar; Lisa Winston; Joseph F John; Christine J Kubin; Rohit Talwani; Thomas Moore; Joseph M Patti; Seth Hetherington; Michele Texter; Eric Wenzel; Violet A Kelley; Vance G Fowler
Journal:  Antimicrob Agents Chemother       Date:  2006-08       Impact factor: 5.191

3.  Is methicillin-resistant Staphylococcus aureus replacing methicillin-susceptible S. aureus?

Authors:  Elizabeth Mostofsky; Marc Lipsitch; Gili Regev-Yochay
Journal:  J Antimicrob Chemother       Date:  2011-07-07       Impact factor: 5.790

4.  Population-based epidemiology of Staphylococcus aureus bloodstream infection: clonal complex 30 genotype is associated with mortality.

Authors:  A Blomfeldt; A N Eskesen; H V Aamot; T M Leegaard; J V Bjørnholt
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-02-12       Impact factor: 3.267

Review 5.  Population-based epidemiology and microbiology of community-onset bloodstream infections.

Authors:  Kevin B Laupland; Deirdre L Church
Journal:  Clin Microbiol Rev       Date:  2014-10       Impact factor: 26.132

6.  Prevalence of infective endocarditis in patients with Staphylococcus aureus bacteraemia: the value of screening with echocardiography.

Authors:  Rasmus V Rasmussen; Ulla Høst; Magnus Arpi; Christian Hassager; Helle K Johansen; Eva Korup; Henrik C Schønheyder; Jens Berning; Sabine Gill; Flemming S Rosenvinge; Vance G Fowler; Jacob E Møller; Robert L Skov; Carsten T Larsen; Thomas F Hansen; Shan Mard; Jesper Smit; Paal S Andersen; Niels E Bruun
Journal:  Eur J Echocardiogr       Date:  2011-06

7.  Prevalence and outcomes of antimicrobial treatment for Staphylococcus aureus bacteremia in outpatients with ESRD.

Authors:  Kevin E Chan; H Shaw Warren; Ravi I Thadhani; David J R Steele; Jeffrey L Hymes; Franklin W Maddux; Raymond M Hakim
Journal:  J Am Soc Nephrol       Date:  2012-08-16       Impact factor: 10.121

8.  Salmonella enterica bacteraemia: a multi-national population-based cohort study.

Authors:  Kevin B Laupland; Henrik C Schønheyder; Karina J Kennedy; Outi Lyytikäinen; Louis Valiquette; John Galbraith; Peter Collignon
Journal:  BMC Infect Dis       Date:  2010-04-14       Impact factor: 3.090

9.  Rationale for and protocol of a multi-national population-based bacteremia surveillance collaborative.

Authors:  Kevin B Laupland; Henrik C Schønheyder; Karina J Kennedy; Outi Lyytikäinen; Louis Valiquette; John Galbraith; Peter Collignon; Deirdre L Church; Daniel B Gregson; Pamela Kibsey
Journal:  BMC Res Notes       Date:  2009-07-22

10.  Geographic distribution of Staphylococcus aureus causing invasive infections in Europe: a molecular-epidemiological analysis.

Authors:  Hajo Grundmann; David M Aanensen; Cees C van den Wijngaard; Brian G Spratt; Dag Harmsen; Alexander W Friedrich
Journal:  PLoS Med       Date:  2010-01-12       Impact factor: 11.069

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.